Video wird geladen...
Video konnte nicht geladen werden
Introducing a small portion of proprietary phenomics data from Recursion into the training of MolGPS, our foundation model for molecular property prediction, led to massive performance increases on new & existing benchmarks. Learn more about the impact of data & scale.
10,091 Aufrufe • vor 1 Jahr •via X (Twitter)
4 Kommentare

Valence Labsvor 1 Jahr
Positive effects were apparent in our initial experiments with the 1B parameter version of MolGPS. The inclusion of @RecursionPharma's data led to an improvement equivalent to scaling the model by a factor of 50. Read the paper for more details:

Valence Labsvor 1 Jahr
Further scaling of the model to 3B parameters led to continued performance gains on ADME and protein binding tasks in @Polaris_HQ, a new benchmarking platform for drug discovery. Explore the results here:

Squeeze Kidvor 1 Jahr
@RecursionPharma $RXRX

Squeeze Kidvor 1 Jahr
@RecursionPharma @afterhourbot hunt great video to understand what $RXRX does


![[Ep #21] Is the matrix already here? We chat with Art | Zoro ⟬⊻⟭, Co-Founder of vana delving into his pivot from law to data science & Vana's mission: giving individuals ownership of their data Data aggregation, importance of synthetic data for AI & need for digital autonomy](https://image.24vids.com/tw-1975546660559224850/media/G2nRSXtXwAEDI8A.jpg)